-
Nasdaq ends best quarter in 6 years as yen extends drop against dollar
-
Serena beaten at Wimbledon in first singles match in four years
-
Zverev says Wimbledon hopes 'about me' despite open draw
-
Dutch football chiefs condemn online racism after World Cup exit
-
Lionel Scaloni: Argentina's mastermind marks 100 games in charge
-
Police hunt for Monaco bomber after Ukraine-born tycoon wounded
-
Mourinho's Real Madrid host Real Sociedad in La Liga opener
-
CIA boss compares cutting-edge AI to nuclear weapons
-
Football brings joy to Venezuelan kids displaced by quakes
-
'Any team can beat you', warns Ruiz as Spain seek end to World Cup woe
-
Haaland fires Norway into last 16 as France, Mexico look to advance
-
Venezuela quake survivors seek food, shelter as toll rises to nearly 2,000
-
Merkel unveils official portrait for German chancellery
-
Haaland scores winner to send Norway into last-16 Brazil clash
-
Canada crews battle northern wildfire after crash kills 3
-
US Treasury sanctions target alleged drug cartel-linked fuel smuggling ring
-
Portugal's Silva bides his time after being benched at World Cup
-
LeBron James to leave Lakers to play 24th NBA season
-
US stars relish soccer's primetime moment against Bosnia
-
Zverev wins in four sets to reach Wimbledon round two
-
Lampard extends Coventry stay after promotion to Premier League
-
Grimaldo realises goal of Atletico Madrid move from Leverkusen
-
Djokovic, Sinner aim to step up Wimbledon title chase
-
US Supreme Court lifts campaign spending restrictions ahead of midterms
-
Brook ready for "great honour" of succeeding Stokes as Test skipper
-
LeBron James to leave Lakers to play 24th NBA career
-
Taps run dry in Hungarian village as heatwave bites
-
Tens of millions swelter as heat wave blasts US
-
Venezuela quake survivors seek food, shelter amid risk of disease outbreaks
-
US Supreme Court rejects Trump bid to limit birthright citizenship
-
LeBron James to leave Lakers, continue NBA career - media reports
-
Gardner stars as Australia thrash the West Indies in Women's T20 World Cup semi-final
-
'Where is she?' The desperate search for Venezuela's missing
-
Former Barca teen star Fati seals permanent Monaco switch
-
No business as usual after shock World Cup exit, say German FA
-
German rail regulator backs Italian firm in competition spat
-
Pope appeals to Catholic traditionalists to avoid schism
-
Ancelotti shows Brazil his worth at World Cup but concerns remain
-
US Supreme Court upholds transgender sports bans
-
Stocks rise, yen at 40-year low against dollar
-
US Supreme Court rejects Trump bid to restrict birthright citizenship
-
Australia hold West Indies to 125-7 in World Cup semi-final
-
Serena set for remarkable Wimbledon return, Swiatek survives scare
-
Defending champ Swiatek survives scare to reach Wimbledon second round
-
Africa EV firm Spiro accused of torturing Uganda employees
-
US Supreme Court upholds state bans on transgender athletes in school
-
PSG's Portugal forward Ramos signs five-year AC Milan deal
-
Tourists soldier on in Rome despite heatwave
-
Inflation slows in top eurozone economies as ECB ponders next move
-
Record number of 'new millionaires' in 2025, says UBS
Applied DNA Reschedules Investor Update Call in Observance of the National Day of Mourning in Recognition of the Passing of Former President Jimmy Carter
Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a leader in polymerase chain reaction (PCR)-based technologies, today announced that it has rescheduled its Investor Update call to Thursday, February 13, 2025, to coincide with the release of its first quarter fiscal 2025 financial results.
The Company originally scheduled an Investor Update call for January 9, 2025, to update shareholders on its strategic restructuring announced in December 2024 and GMP initiative. The change reflects the observance of the National Day of Mourning in recognition of the passing of former President Jimmy Carter.
About Applied DNA Sciences
Applied DNA Sciences is a biotechnology company developing technologies to produce and detect deoxyribonucleic acid ("DNA"). Using the polymerase chain reaction ("PCR") to enable both the production and detection of DNA, we currently operate in three primary business markets: (i) the enzymatic manufacture of synthetic DNA for use in the production of nucleic acid-based therapeutics and the development and sale of a proprietary RNA polymerase ("RNAP") for use in the production of mRNA therapeutics; and, (ii) the detection of DNA and RNA in molecular diagnostics and genetic testing services; and (iii) the manufacture and detection of DNA for industrial supply chain security services.
Visit adnas.com for more information. Follow us on X and LinkedIn. Join our mailing list.
For additional information:
Investor Relations: Sanjay M. Hurry, 917-733-5573, [email protected]
Web: https://investors.adnas.com/
SOURCE: Applied DNA Sciences, Inc.
N.Mitchell--AT